Reduction of 5-fluorouracil toxicity with allopurinol
Garin, A.M.; Mamedov, F.F.
Vestnik Akademii Meditsinskikh Nauk SSSR 3: 77-79
1985
ISSN/ISBN: 0002-3027 PMID: 3993195 Document Number: 262252
Document emailed within 1 workday
Related Documents
Schwartz, P.M.; Dunigan, J.M.; Marsh, J.C.; Handschumacher, R.E. 1980: Allopurinol modification of the toxicity and antitumor activity of 5-fluorouracil Cancer Research 40(6): 1885-1889Van der Vliet, W.; Erlichman, C.; Elhakim, T. 1989: Allopurinol mouthwash for prevention of fluorouracil-induced stomatitis Clinical Pharmacy 8(9): 655-658
Schuster, O.; Haertel, M.; Hugemann, B.; Gikalov, I.; Schiemann, O.; Fenner, H. 1985: The clinical pharmacokinetics of allopurinol. 1. Allopurinol absorption sites and dose proportionality of allopurinol/oxipurinol bioavailability Arzneimittel-Forschung 35(4): 760-765
Yokomizo, H.; Yoshimatsu, K.; Hashimoto, M.; Ishibashi, K.; Umehara, A.; Yoshida, K.; Fujimoto, T.; Watanabe, K.; Ogawa, K. 2004: Prophylactic efficacy of allopurinol ice ball for leucovorin/5-fluorouracil therapy-induced stomatitis Anticancer Research 24(2c): 1131-1134
Ohtani, H.; Arimoto, Y.; Nishio, K.; Kanamiya, Y.; Oba, H.; Adachi, K.; Shintani, M.; Nakamura, R.; Yui, S. 2008: Efficacy and toxicity of fluorouracil, leucovorin plus oxaliplatin (FOLFOX4 and modified FOLFOX6) followed by fluorouracil, leucovorin plus irinotecan(FOLFIRI)for advanced or metastatic colorectal cancer--case studies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(10): 1769-1774
Tsavaris, N.; Zinelis, A.; Karvounis, N.; Beldecos, D.; Mylonacis, N.; Zamanis, N.; Bacoyannis, C.; Valilis, P.; Antonopoulos, A.; Kosmidis, P. 1990: Multimodal biochemical modulation of 5-fluorouracil activity in advanced colorectal cancer with allopurinol, folinic acid and dipyridamol Journal of Chemotherapy 2(2): 123-126
Walker, R.I.; Horvath, W.L.; Rule, W.S.; Herion, J.C.; Palmer, J.G. 1973: The failure of allopurinol to enhance 6-mercaptopurine toxicity in rabbits Cancer Research 33(4): 755-758
Naas, J.E.; Sanders, L.J. 1998: Chronic tophaceous gout in a patient with a history of allopurinol toxicity Cutis 62(5): 239-241
Rexroth, G.; Scotland, V. 1994: Cardiac toxicity of 5-fluorouracil Medizinische Klinik 89(12): 680-688
Bounous, G.; Pageau, R.; Regoli, D. 1978: The role of diet on 5-fluorouracil toxicity International Journal of Clinical Pharmacology and Biopharmacy 16(11): 519-522
Jedrzychowska, A.; Dołegowska, B. 2013: Dihydropirymidine dehydrogenase (DPD)--a toxicity marker for 5-fluorouracil? Annales Academiae Medicae Stetinensis 59(2): 48-53
Popovic, P.; Popovic, V.; Baughman, J. 1982: Circadian rhythm and 5-fluorouracil toxicity in C3H mice Progress in Clinical and Biological Research 107: 185-187
Bruckner, H.W.; Spigelman, M. 1988: Leucovorin as a clinical potentiator of 5-fluorouracil toxicity and anticancer efficacy Mount Sinai Journal of Medicine new York 55(5): 390-394
Stanford, F.R.; Carey, L.C.; King, D.R.; Anderson, G.W. 1976: Adverse effects of elemental diets on tolerance for fluorouracil (5-fu) toxicity in rats Surgical Forum 27(62): 42-43
Merkulov, M.F.; Leskova, S.G.; Rudenskaia, G.N. 1971: Dependence of the toxicity and antineoplastic activity of 5-fluorouracil solutions on the incubation time at 37 degrees Farmakologiia i Toksikologiia 34(5): 621-626
Laudani, A.; Gebbia, V.; Leonardi, V.; Savio, G.; Borsellino, N.; Cusimano, M.Pia.; Calabria, C.; Stefano, R.; Agostara, B. 2004: Activity and toxicity of oxaliplatin plus raltitrexed in 5-fluorouracil refractory metastatic colorectal adeno-carcinoma Anticancer Research 24(2c): 1139-1142
Sismondi, P.; Zola, P.; Galletto, L.; De Giovanni, D.; Giardina, G. 1979: Evaluation of the toxicity of precautional chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in carcinoma of the breast in the first 700 treatment cycles Minerva Ginecologica 31(7-8): 563-568
Danhauser, L.L.; Rustum, Y.M. 1979: A method for continuous drug infusion in unrestrained rats: its application in evaluating the toxicity of 5-fluorouracil/thymidine combinations Journal of Laboratory and Clinical Medicine 93(6): 1047-1053
Cao, S.; Troutt, A.B.; Rustum, Y.M. 1998: Interleukin 15 protects against toxicity and potentiates antitumor activity of 5-fluorouracil alone and in combination with leucovorin in rats bearing colorectal cancer Cancer Research 58(8): 1695-1699
Akkasilpa, S.; Osiri, M.; Deesomchok, U.; Avihingsanon, Y. 2004: The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia Journal of the Medical Association of Thailand 87(9): 1087-1091